Brief: Replicel Life Sciences continues restructuring with share structure consolidation
23/07/2016 24:05
July 22 (Reuters) - Replicel Life Sciences Inc RP.V
* Replicel Life Sciences continues restructuring with share
structure consolidation
* Says its board of directors has authorized a plan to
proceed with a consolidation of its outstanding common shares
Source text for Eikon: urn:newsml:reuters.com:*:nMKW1DbsMa
Further company coverage: RP.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector